about
Stepwise approach to myopathy in systemic diseaseNew aspects in the management of pneumoniaDexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte DifferentiationThe effects of omega-3 fatty acid supplementation on dexamethasone-induced muscle atrophy.Use of dexamethasone in patients with high-grade glioma: a clinical practice guidelineAssessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling.The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain TransitionGlucocorticoid-induced myopathy in the intensive care unit.Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells?Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.Fracture rate in patients with myasthenia gravis: the general practice research database.Novel approaches to corticosteroid treatment in Duchenne muscular dystrophyGlucocorticoid-induced bone loss is associated with abnormal intravertebral areal bone mineral density distribution.Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism.Steroid myopathy: some unresolved issues.Corticosteroid-use in primary and secondary brain tumour patients: a review.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Implications of glucocorticoid therapy in idiopathic inflammatory myopathies.Proximal myopathy: diagnostic approach and initial management.Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment.The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.Corticosteroid use in neuro-oncology: an update.Aggravation of fatigue by steroid therapy in terminally ill patients with cancer.Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism.Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center.Acute myopathy following intra-muscular injection of compound betamethasone: A case report.A retrospective review of fall risk factors in the bone marrow transplant inpatient service.Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.Relapse of polymyalgia rheumatica after a fall.Physical Fatigue, Fitness, and Muscle Function in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Respiratory muscle strength and pulmonary function in children with rhinitis and asthma after a six-minute walk test.Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients.Diagnostic work-up in steroid myopathy.Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients.The association between glucocorticoid therapy and BMI z-score changes in children with acute lymphoblastic leukemia.Effects of eldecalcitol on bone and skeletal muscles in glucocorticoid-treated rats.Efficacy of immunosuppressive treatment in a systemic lupus erythematosus patient presenting with inclusion body myositis.
P2860
Q21090471-A18F96E9-9523-4F2E-952F-72D35066228BQ28080025-52EF179E-B439-4669-8908-D9ABF4CAA12AQ33717152-A70684C1-BF0A-4111-B130-4E362A95B800Q33748505-45CB096F-872D-451A-BEED-8360B69E19CAQ33763941-4B278672-67F8-4379-BFF0-B72C960234F1Q33781082-5E6FD111-701B-42CE-8D2C-A88DE192DBB2Q34483183-FC3D8A47-40C6-4A23-9F03-5DB3B8C04345Q35135088-A8431CD2-4B92-4E30-BEEC-5E004F71F79EQ35656679-F8200918-0440-44DB-81B4-9410E73B9C29Q35691817-FF984641-6BAF-4992-B5D5-404AE36B70C5Q35972062-3BFE9D9C-F42A-476D-9A90-70739055DAE6Q36484399-D04038C2-6036-4BE6-8370-3DF57FB81D60Q36568701-717D0CD6-7C30-415C-B19A-2640BDD1645CQ36712243-4C319358-882E-49E8-B17D-B50A74BFE541Q36869575-8C6A59FB-1FF1-4886-9FFB-709F6BEA5743Q37105605-8D2C81B5-E037-44E9-9CCF-2E3EC410F284Q37478926-73C69975-9CD0-4FCF-9CB6-97FCF8D7CF28Q37890215-FE9631ED-CC76-483C-9589-0B671C6FC1FDQ37942476-25768C71-2DC2-42AA-9D1E-DFB7EAC24E39Q38015162-487E54D9-AA41-4074-9E9A-DC8DBAF24688Q38017953-EC253C87-6E6C-424B-BDCB-530F3F4C1509Q38099824-4C6B7FAB-C73A-4912-AA7A-23149D2FDC5DQ38148190-B6D06A89-1B5A-4793-8756-911EBAFBB4B2Q38436495-9318B185-5E8A-4AFE-A933-488B8C0F84C7Q38512587-4F2BBE9E-EA85-4EED-8B1D-45C7E51E6DEBQ39229054-0502B9A0-A93D-4B44-BEB2-B92088DBA3DDQ39429075-8947E54B-B56F-4DC7-9042-79E9B4A3D582Q40711379-052EA904-A6A3-4DA6-B839-66C3F040347BQ41523663-FE422BD1-BEDC-4C35-9C19-E01B14D8BE42Q47183946-3C2F0D56-798C-45CF-896E-129E8D32F9EFQ47304222-2E88A8B7-10A3-4B41-9D10-6F5451DDE23BQ47448179-40A2551A-1510-44B2-A56F-F68ED454FB63Q47603537-41604582-5AEA-4098-BE9D-77EFD2A223E5Q47896431-06F394E0-C3ED-4840-B928-EFBF56A23243Q48038691-0A242F36-7E98-47CF-994E-2ACB6ED8BBE5Q48048854-08E68818-33D9-4862-AD1C-6A7752C2924BQ48476809-B73C44C8-98F2-469B-8A5C-932AB405DD1BQ50561839-28CA0C4D-BDB1-4857-B2C1-0041B6B5141FQ51027441-B05380F9-DC16-453E-BBB8-530DDE6D37A4Q53764444-BD695852-BDDB-46EE-AAE2-3D8AFEADA014
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucocorticoid-induced myopathy.
@en
Glucocorticoid-induced myopathy.
@nl
type
label
Glucocorticoid-induced myopathy.
@en
Glucocorticoid-induced myopathy.
@nl
prefLabel
Glucocorticoid-induced myopathy.
@en
Glucocorticoid-induced myopathy.
@nl
P1433
P1476
Glucocorticoid-induced myopathy.
@en
P2093
Jozélio Freire de Carvalho
Rosa Maria Rodrigues Pereira
P356
10.1016/J.JBSPIN.2010.02.025
P577
2010-05-14T00:00:00Z